Aksoy, O., Pencik, J., Hartenbach, M., Moazzami, A. A., Schlederer, M., Balber, T., Varady, A., Philippe, C., Baltzer, P. A., Mazumder, B., Whitchurch, J. B., Roberts, C. J., Haitel, A., Herac, M., Susani, M., Mitterhauser, M., Marculescu, R., Stangl-Kremser, J., Hassler, M. R., Kramer, G., Shariat, S. F., Turner, S. D., Tichy, B., Oppelt, J., Pospisilova, S., Hartenbach, S., Tangermann, S., Egger, G., Neubauer, H. A., Moriggl, R., Culig, Z., Greiner, G., Hoermann, G., Hacker, M., Heery, D. M., Merkel, O., & Kenner, L. (2021). Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer. International Journal of Cancer, 148(3), 731-747.